BioMarin Pharmaceutical | SCHULD



Debt Veränderung Datum
Acadia Pharmaceuticals USD 56.29M 56.29M 2025-06
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 56.2B 1.18B 2025-06
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
Incyte USD 42.41M 5.29M 2025-06
Insmed USD 564.1M 567.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
PTC Therapeutics USD 286.01M 2.12B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 22.28B 4.38B 2025-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


BioMarin Pharmaceutical SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.